Table 3

Bone marrow morphology, p-STAT5 IHC and molecular data

CaseCellularity (%)Megakaryocyte morphologyMarrow fibrosisp-STAT5 IHCJAK2 V617FCALR exon 9 mutation
140Small, hypolobatedMF-0PosNegNS
290Small, hypolobatedMF-2PosNegNeg
3100Small, hypolobatedNEPosNegNeg
460Varying size, hypolobatedMF-1PosNegNeg
590Small, hypolobatedNEPosNegNeg
6100Small, hypolobatedMF-0NegNegNS
7*NENENE
7†90Large with complex lobationsMF-2PosPosNS
8100Small, hypolobatedNEPosNegNeg
9>90Small, hypolobatedNEPosNegNeg
10>90Small, hypolobatedNEPosNegNeg
11>90Small, hypolobatedNEPosNegNS
1290Small, hypolobated; MKBL presentMF-2NegNegNeg
  • *At diagnosis.

  • †27 months after initial diagnosis.

  • CALR, calreticulin; IHC, immunohistochemistry; MF-0, scattered linear reticulin with no intersections corresponding to normal bone marrow; MF-1, loose network of reticulin with many intersections, especially in perivascular areas; MKBL, megakaryoblasts; NE, not evaluated; Neg, negative; NS, not successful; Pos, positive; p-STAT5, phospho-STAT5.